What is Dosentrx?
Dosentrx is a digital health and medication management technology company dedicated to revolutionizing how patients manage specialty oral medications at home. Its integrated ReX platform combines hardware, software, and clinical workflow tools designed to support individuals undergoing complex therapies, particularly in oncology and other specialty pharmaceutical treatment areas. The company aims to improve adherence and outcomes for patients managing challenging treatment regimens.
How much funding has Dosentrx raised?
Dosentrx has raised a total of $1.8M across 1 funding round:
Private Equity
$1.8M
Private Equity (2026): $1.8M, investors not publicly disclosed
What's next for Dosentrx?
With a major enterprise-level funding context and a recent strategic investment, Dosentrx is positioned for significant scaling and market expansion. This capital injection will likely fuel further development of its ReX platform, enhance its clinical workflow integration, and broaden its reach within the oncology and specialty pharmaceutical markets. The company's focus on patient-centric technology for complex medication management indicates a strategic move towards addressing critical unmet needs in chronic disease care.
See full Dosentrx company page
